# Zilver® PTX® V Clinical Study

Study · id `cardio:ct-nct01901289` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01901289](<https://clinicaltrials.gov/study/NCT01901289>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01901289

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT01901289. Allocation not applicable; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2016-11-18 (actual). Results posted on 2018-07-03.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Start date: 2013-08 (registry gives no type) (ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Primary completion: 2016-11-18 (actual) (ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Completion: 2021-02-15 (actual) (ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Results first posted: 2018-07-03 (ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01901289, source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01901289-2022-03-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Zilver® PTX® V Clinical Study
- Condition: Peripheral Arterial Disease
- Intervention (Device): Zilver® PTX® Drug-Eluting Peripheral Stent
- Lead sponsor: Cook Research Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cook Research Incorporated (`cardio:org-cook-research-incorporated`)

## Provenance

Content hash: 86c48dca35e3fca31717b034285c6d2babf2d86b772a17c1fb6655da88933a76
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
